Novartis, Dynavax to develop "universal" flu shots

07/24/2008 | American City Business Journals

Novartis Vaccines and Diagnostics agreed to supply its trivalent influenza vaccine that will be used in developing Dynavax Technologies' experimental "universal" flu vaccine. In return, Novartis gains the exclusive option to discuss development and marketing deals with Dynavax. Financial terms of the partnership were not disclosed.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR